文献速递围术期管理与 ERAS急腹症与外科感染

术前高剂量阿片类药物患者术后阿片消耗与续方模式

Opioid Consumption and Fills after Operation in Adults on High-Dose Prescription Opioids.
PubMed 文献 · J Am Coll Surg · 2026-03-13

该回顾性队列研究基于密歇根外科质量协作组与州处方药监测计划数据,比较了2019至2022年间接受手术的成人中,术前高剂量、低剂量及未使用阿片类药物患者的术后30天阿片消耗与90天续方情况。结果显示高剂量患者30天消耗与未使用者临床相似,但90天续方频率和总量显著更高。

要点

  • 术前高剂量阿片患者术后30天消耗与未使用者临床相似。
  • 高剂量患者90天续方率48.3%,远高于低剂量27.1%和未使用8.2%。
  • 高剂量患者术后日均用量未超过术前基线水平。

核心结论

  • 术前高剂量阿片暴露患者术后30天消耗与未使用者临床相似,但90天续方显著更多且通常未超过基线剂量。

研究设计与样本

  • 回顾性队列研究,纳入2019年1月1日至2022年5月15日在密歇根外科质量协作组接受手术的成人,并与州处方药监测计划数据链接。
  • 共72,616例患者,其中高剂量5,346例、低剂量14,180例、未使用53,090例。
  • 高剂量定义为至少1天使用≥30 mg羟考酮当量或任何缓释阿片类药物。
  • 主要终点为30天患者报告阿片消耗(羟考酮5 mg当量),次要终点为90天术后续方。
  • 采用调整的零膨胀负二项模型及聚类稳健标准误。

主要发现

  • 调整后30天平均消耗:高剂量4.6片(95%CI 4.3-4.9),低剂量3.9片(3.8-4.1),未使用3.2片(3.1-3.3)。
  • 30天消耗75百分位:高剂量7.9片,低剂量6.7片,未使用5片。
  • 90天续方率:高剂量48.3%,低剂量27.1%,未使用8.2%。
  • 90天续方总量75百分位:高剂量360片,低剂量92片,未使用24片。
  • 高剂量患者术后日均阿片用量与术前相似或更低。

临床怎么用

  • 围术期计划应强调与患者常规处方医生协调,防止碎片化、长期阿片使用。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Preoperative high-dose opioid use complicates perioperative pain management, yet postoperative consumption and refill patterns relative to opioid-naive patients remain poorly defined. We compared 30-day opioid consumption and 90-day prescription fills after common surgical procedures by preoperative opioid exposure. STUDY DESIGN: We conducted a retrospective cohort study of adults undergoing operation (January 1, 2019, to May 15, 2022) in the Michigan Surgical Quality Collaborative linked to statewide Prescription Drug Monitoring Program data. Patients were categorized as high-dose (1 day or more with greater than or equal to 30 mg oxycodone equivalents or any extended-release opioid), low dose, or opioid naive. The primary endpoint was 30-day patient-reported opioid consumption (oxycodone 5 mg equivalents). Secondary outcomes included 90-day postoperative fills. Adjusted zero-inflated negative binomial models with clustered robust SEs were used. RESULTS: Among 72,616 patients (5,346 high dose; 14,180 low dose; 53,090 opioid naive), adjusted mean 30-day consumption was 4.6 pills (95% CI 4.3 to 4.9) for high-dose patients, 3.9 (3.8 to 4.1) for low-dose, and 3.2 (3.1 to 3.3) for opioid-naive patients. The 75th percentile consumption was 7.9, 6.7, and 5 pills, respectively. In contrast, 90-day fills were substantially more frequent among high-dose patients (48.3%) compared with low-dose patients (27.1%) and opioid-naive patients (8.2%). At the 75th percentile, the total 90-day fill size was 360 pills for high-dose patients vs 92 and 24 pills, respectively. Among high-dose patients, mean daily postoperative opioid use was similar to or lower than preoperative levels. CONCLUSIONS: Patients with high-dose preoperative opioid exposure report clinically similar 30-day postoperative consumption as opioid-naive patients but experience substantially greater 90-day prescription refills, generally without escalation beyond baseline dosing. Perioperative planning should emphasize coordination with usual prescribers to prevent fragmented, prolonged opioid use.

来源:J Am Coll Surg,查看原文。版权归原作者所有。

引用

  1. Bicket MC, McGee MF, Gunaseelan V, et al. Opioid Consumption and Fills after Operation in Adults on High-Dose Prescription Opioids. J Am Coll Surg. 2026. PMID: 41823296. doi:10.1097/XCS.0000000000001919

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。